Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Development and Validation of a Prognostic Score for Early Mortality after Allogeneic Stem-Cell Transplantation for Acute Lymphoblastic Leukemia in Latin America: A Multinational Study

Wellington F. Silva, Andres Gomez-De Leon, Dalila Cysne, Fernando J Medina-Olivares, Alexia González-Lozano, Mariana Nassif Kerbauy, Iago Colturato, Ana Maia, Luciana Tucunduva, George Barros, Nelson Hamerschlak, Vergilio Colturato, Vanderson Rocha

Blood (2024) 144 (Supplement 1): 7298.

https://doi.org/10.1182/blood-2024-210780

Published: 2024

Journal Articles

Clinical Determinants of Early Mortality Following Allotransplantation for Acute Lymphoblastic Leukemia in a Brazilian Multicenter Registry

Dalila Cysne, Wellington F Silva, Mariana Nassif Kerbauy, Iago Colturato, Ana Maia, Luciana Tucunduva, George Barros, Vergilio Colturato, Nelson Hamerschlak, Vanderson Rocha

Blood (2023) 142 (Supplement 1): 2167.

https://doi.org/10.1182/blood-2023-182057

Published: 2023

Journal Articles

Dynamics of Immune Reconstitution after Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide Compared to Classical Immunosuppression with ATG

Mariana Nassif Kerbauy, Fernanda Agostini Rocha, Leonardo Javier Arcuri, Priscila Silva Cunegundes, Clarisse MARTINS Machado, Andreza Feitosa Ribeiro, Lucila Nassif Kerbauy, Luciana Cavalheiro Marti, Nelson Hamerschlak

Blood (2023) 142 (Supplement 1): 3574.

https://doi.org/10.1182/blood-2023-188052

Published: 2023

Journal Articles

Evaluation of the Impact of the Disease Risk Index and Pre-Transplant Measurable Residual Disease By Flow Cytometry As Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia

Carolina Perrone Marques, Ana Carolina de Almeida Silveira, Jade Zezzi, Felipe Galvão Batista Chaves, Juliana Dall'Agnol da Rocha, Renata Leati Stanzione, Mariana Nassif Kerbauy, Nelson Hamerschlak, Fabio P. S. Santos, Leonardo Javier Arcuri, Andreza Feitosa Ribeiro

Blood (2023) 142 (Supplement 1): 7438.

https://doi.org/10.1182/blood-2023-190786

Published: 2023

Journal Articles

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Leonardo Javier Arcuri, Fabio Pires de Souza Santos, Lucila Kerbauy, Mariana Nassif Kerbauy, Andreza Feitosa Ribeiro, Nelson Hamerschlak

Blood (2022) 140 (Supplement 1): 4767–4769.

https://doi.org/10.1182/blood-2022-156282

Published: 2022

Journal Articles

Risk Factors for Adverse Outcomes Following Haploidentical Hematopoietic Cell Transplantation with Posttransplant Cyclophosphamide: A Two-Center Analysis

Viviane De Jesus Torres Lima, Anderson Felipe Felipe Da Silva, Andreza Alice Feitosa Ribeiro, Mariana Nassif Kerbauy, Lucila Kerbauy, Cinthya Correa Silva, Leonardo Javier Arcuri, Nelson Hamerschlak

Blood (2021) 138 (Supplement 1): 4889.

https://doi.org/10.1182/blood-2021-153961

Published: 2021

Journal Articles

Predictive Factors and Outcomes after Allogeneic Stem-Cell Transplantation for Adults with Acute Lymphoblastic Leukemia in Brazil

Wellington F Silva, Dalila Cysne, Mariana Nassif Kerbauy, Iago Colturato, Ana Carolina Arrais Maia, Luciana Tucunduva, George Barros, Vergilio Rensi Colturato, Nelson Hamerschlak, Vanderson Rocha

Blood (2021) 138 (Supplement 1): 2926.

https://doi.org/10.1182/blood-2021-153547

Published: 2021

Journal Articles

PET-CT Quantitative Parameter Delta Suvmax As a Predictor of Early Relapse in Patients with Difuse Large B-Cell Lymphoma

Carolina Feres, Guilherme Fleury Perini, Carolina Leme de Moura Pereira, Larissa Lane Cardoso Teixeira, Mariana Nassif Kerbauy, Jackson Alex Barbosa, Denise Cunha Pasqualin, Leonardo Javier Arcuri, Nelson Hamerschlak

Blood (2021) 138 (Supplement 1): 4580.

https://doi.org/10.1182/blood-2021-153615

Published: 2021

Journal Articles

Implementation of a Public Lymphoma Clinic in a Private Hospital in Brazil: Challenges and Impact of Delayed Diagnosis in Patients with Diffuse Large B Cell Lymphoma

Guilherme Fleury Perini, Larissa LC Teixeira, Carolina Feres, MD, Mariana Nassif Kerbauy, MD, Leonardo Javier Arcuri, Denise Cunha Pasqualin, Alanna MPS Bezerra, Diogo DG Bugano, Nelson Hamerschlak, MD PhD

Blood (2020) 136 (Supplement 1): 13–14.

https://doi.org/10.1182/blood-2020-142738

Published: 2020

Journal Articles

Cell of Origin Impacts Δsuvmax Cutoff for Prediction of Relapse in Patients with Diffuse Large B-Cell Lymphoma

Carolina Feres, MD, Leonardo Javier Arcuri, Larissa LC Teixeira, Mariana Nassif Kerbauy, MD, Denise Cunha Pasqualin, Alanna MPS Bezerra, Guilherme de Carvalho Campos Neto, MD, Rafael Fernandes Nunes, Aline Fernanda Ramos, MD, Michelle De Paula Jacinto, Guilherme Fleury Perini, MD, Nelson Hamerschlak, MD PhD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-143305

Published: 2020

Journal Articles

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients

Clarisse MARTINS Machado, MD PhD, Mariana Nassif Kerbauy, MD, Iago Colturato, MD, Leonardo Javier Arcuri, Ana Cláudia Ferrari dos Santos, MSc, Fernanda Rodrigues Silva, MD, Anderson João Simioni, Juliana Folloni Fernandes, MD, Mair Pedro de Souza, MD, Vergilio Rensi Colturato, MD, Nelson Hamerschlak, MD PhD

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-141959

Published: 2020

Journal Articles

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Naveed Ali, MD, Ana Carolina Pires de Rezende, MD, Folashade Otegbeye, MBBChir,MPH, Mariana Nassif Kerbauy, MD, Brenda W. Cooper, MD, David Mansur, MD, Gisele Pereira, PhD, Roberto Sakuraba, MD, Benjamin K. Tomlinson, MD, Kirsten M Boughan, DO, Cinthya Correa Silva, MD, Leland Metheny, III, MD, Andreza Feitosa Ribeiro, MD, Molly M Gallogly, MDPhD, Ehsan Malek, MD, EDuardo Weltman, MD, Marcos de Lima, MD, Nelson Hamerschlak, MD PhD, Paolo F Caimi, MD

Blood (2020) 136 (Supplement 1): 29–30.

https://doi.org/10.1182/blood-2020-142197

Published: 2020

Journal Articles

Autologous Stem Cell Transplantation (ASCT) As Upfront Treatment in Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Comparative Analysis in Clinical Trials Setting

Mariana Nassif Kerbauy, MD, Fabio Ynoe de Moraes, MD, Lucila Nassif Kerbauy, MD, Iracema Esteves, MD PhD, Guilherme Fleury Perini, MD, Fabio Pires de Souza Santos, MD, Andreza Alice Feitosa Ribeiro, MD PhD, Fabio Rodrigues Kerbauy, MD PhD, Nelson Hamerschlak, MD PhD

Blood (2016) 128 (22): 2272.

https://doi.org/10.1182/blood.V128.22.2272.2272

Published: 2016

Journal Articles

Early MMF Discontinuation Is an Effective and Safe Measure to Decrease CMV Reactivation in Patients Submitted to Unmanipulated Haploidentical Transplant with Post-Cy Immunosuppression

Mariana Nassif Kerbauy, MD, Lucila Nassif Kerbauy, MD, Iracema Esteves, MD PhD, Jairo Jose Nascimento Sobrinho, MD, Jose Mauro Kutner, MD PhD, Morgani Rodrigues, MD, Fabio Pires de Souza Santos, MD, Guilherme Fleury Perini, MD, Luis Fernando Aranha Camargo, MD PhD, Jacyr Pasternak, MD PhD, Juliana Folloni Fernandes, MD, Luiz Fernando Alves Lima Mantovani, MD, Angela Mandelli Venancio, MD, Gabriele Zamperlini Netto, MD, Cinthya Corrêa da Silva, Fabio Rodrigues Kerbauy, MD PhD, Andreza Alice Feitosa Ribeiro, MDPhD, Nelson Hamerschlak, MD PhD

Blood (2016) 128 (22): 2216.

https://doi.org/10.1182/blood.V128.22.2216.2216

Published: 2016

Journal Articles

Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia

Mariana Nassif Kerbauy, MD, Livia Caroline Barbosa Mariano, MD, Erick Menezes, MD, Evandro Dantas, MD, Jayr Schmidt Sobrinho, MD, Marina M Nascimento, MD, Roberto Silva, MD, Maria Cristina Macedo, MD, Sandra Gualandro, MD PhD, Adriana Seber, MD MS

Blood (2015) 126 (23): 4460.

https://doi.org/10.1182/blood.V126.23.4460.4460

Published: 2015

NARROW

Development and Validation of a Prognostic Score for Early Mortality after Allogeneic Stem-Cell Transplantation for Acute Lymphoblastic Leukemia in Latin America: A Multinational Study

Clinical Determinants of Early Mortality Following Allotransplantation for Acute Lymphoblastic Leukemia in a Brazilian Multicenter Registry

Dynamics of Immune Reconstitution after Unrelated Allogeneic Transplantation with Post-Transplantation Cyclophosphamide Compared to Classical Immunosuppression with ATG

Evaluation of the Impact of the Disease Risk Index and Pre-Transplant Measurable Residual Disease By Flow Cytometry As Prognostic Factors in Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia

Impact of Donor Age in the Selection of a Haploidentical or a Matched-Related Donor: A Secondary Analysis of a CIBMTR Database

Risk Factors for Adverse Outcomes Following Haploidentical Hematopoietic Cell Transplantation with Posttransplant Cyclophosphamide: A Two-Center Analysis

Predictive Factors and Outcomes after Allogeneic Stem-Cell Transplantation for Adults with Acute Lymphoblastic Leukemia in Brazil

PET-CT Quantitative Parameter Delta Suvmax As a Predictor of Early Relapse in Patients with Difuse Large B-Cell Lymphoma

Implementation of a Public Lymphoma Clinic in a Private Hospital in Brazil: Challenges and Impact of Delayed Diagnosis in Patients with Diffuse Large B Cell Lymphoma

Cell of Origin Impacts Δsuvmax Cutoff for Prediction of Relapse in Patients with Diffuse Large B-Cell Lymphoma

Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients

Final Results of a Dual-Institution Phase I Clinical Trial of Targeted Marrow Irradiation (TMI) Intensification of Reduced-Intensity Fludarabine/Busulfan (Flu/Bu) Conditioning for Allogeneic Hematopoietic Cell Transplantation for Medically Frail Patients with High-Risk Hematological Malignancies

Autologous Stem Cell Transplantation (ASCT) As Upfront Treatment in Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Comparative Analysis in Clinical Trials Setting

Early MMF Discontinuation Is an Effective and Safe Measure to Decrease CMV Reactivation in Patients Submitted to Unmanipulated Haploidentical Transplant with Post-Cy Immunosuppression

Fertility Outcomes after Allogeneic Hematopoietic Stem Cell Transplants Conditioned with Busulfan 4 Mg/Kg and Cyclophosphamide 200 Mg/Kg to Treat Severe Aplastic Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only